AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 57 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $81,000 | -74.5% | 15,500 | -73.9% | 0.02% | -77.9% |
| Q4 2020 | $318,000 | -26.4% | 59,500 | -33.1% | 0.10% | -49.0% |
| Q3 2020 | $432,000 | +26.3% | 89,000 | +26.4% | 0.20% | -1.0% |
| Q2 2020 | $342,000 | +122.1% | 70,400 | 0.0% | 0.21% | +106.0% |
| Q1 2020 | $154,000 | +77.0% | 70,400 | +369.3% | 0.10% | +194.1% |
| Q4 2019 | $87,000 | – | 15,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $11,479,000 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813,000 | 2.80% |
| Latash Investments, LLC | 243,134 | $284,000 | 0.23% |
| Bracebridge Capital, LLC | 428,571 | $501,000 | 0.09% |
| Running Point Capital Advisors, LLC | 10,000 | $12,000 | 0.01% |
| D.B. Root & Company, LLC | 12,500 | $14,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 406,700 | $475,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $167,000 | 0.00% |
| IFP Advisors, Inc | 6,500 | $104,000 | 0.00% |
| Financial Advocates Investment Management | 27,000 | $32,000 | 0.00% |